9HVB | pdb_00009hvb

High-efficiency Kemp eliminases by complete computational design


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.242 (Depositor), 0.242 (DCC) 
  • R-Value Work: 
    0.192 (Depositor), 0.193 (DCC) 
  • R-Value Observed: 
    0.194 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Complete computational design of high-efficiency Kemp elimination enzymes.

Listov, D.Vos, E.Hoffka, G.Hoch, S.Y.Berg, A.Hamer-Rogotner, S.Dym, O.Kamerlin, S.C.L.Fleishman, S.J.

(2025) Nature 643: 1421-1427

  • DOI: https://doi.org/10.1038/s41586-025-09136-2
  • Primary Citation of Related Structures:  
    9HVB, 9HVG, 9HVH

  • PubMed Abstract: 

    Until now, computationally designed enzymes exhibited low catalytic rates 1-5 and required intensive experimental optimization to reach activity levels observed in comparable natural enzymes 5-9 . These results exposed limitations in design methodology and suggested critical gaps in our understanding of the fundamentals of biocatalysis 10,11 . We present a fully computational workflow for designing efficient enzymes in TIM-barrel folds using backbone fragments from natural proteins and without requiring optimization by mutant-library screening. Three Kemp eliminase designs exhibit efficiencies greater than 2,000 M -1  s -1 . The most efficient shows more than 140 mutations from any natural protein, including a novel active site. It exhibits high stability (greater than 85 °C) and remarkable catalytic efficiency (12,700 M -1  s -1 ) and rate (2.8 s -1 ), surpassing previous computational designs by two orders of magnitude 1-5 . Furthermore, designing a residue considered essential in all previous Kemp eliminase designs increases efficiency to more than 10 5  M -1  s -1 and rate to 30 s -1 , achieving catalytic parameters comparable to natural enzymes and challenging fundamental biocatalytic assumptions. By overcoming limitations in design methodology 11 , our strategy enables programming stable, high-efficiency, new-to-nature enzymes through a minimal experimental effort.


  • Organizational Affiliation
    • Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Kemp eliminase256Escherichia coliMutation(s): 0 
EC: 4.1.1.48
UniProt
Find proteins for P9WFX7 (Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv))
Explore P9WFX7 
Go to UniProtKB:  P9WFX7
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP9WFX7
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.242 (Depositor), 0.242 (DCC) 
  • R-Value Work:  0.192 (Depositor), 0.193 (DCC) 
  • R-Value Observed: 0.194 (Depositor) 
Space Group: P 61
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 98.541α = 90
b = 98.541β = 90
c = 40.483γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
CrystalCleardata reduction
SCALEPACKdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Volkswagen FoundationGermany94747

Revision History  (Full details and data files)

  • Version 1.0: 2025-06-11
    Type: Initial release
  • Version 1.1: 2025-06-25
    Changes: Database references
  • Version 1.2: 2025-07-02
    Changes: Database references
  • Version 1.3: 2025-08-13
    Changes: Database references